Protalix BioTherapeutics
PLX
PLX
44 hedge funds and large institutions have $3.51M invested in Protalix BioTherapeutics in 2024 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 20 reducing their positions, and 27 closing their positions.
Holders
44
Holders Change
-21
Holders Change %
-32.31%
% of All Funds
0.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
5
Reduced
20
Closed
27
Calls
$62K
Puts
$37K
Net Calls
+$25K
Net Calls Change
-$95K
Top Buyers
Top Sellers
1 |
1
Millennium Management
New York
|
$381K |
2 |
2
Goldman Sachs
New York
|
$51.2K |
3 |
3
Northern Trust
Chicago,
Illinois
|
$53.3K |
4 |
4
Jane Street
New York
|
$46.9K |
5 |
YIH
5
Y-Intercept (HK)
Hong Kong
|
$0 |